本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cullinan Therapeutics

7.80
+0.45006.12%
盘后7.800.00000.00%16:19 EDT
成交量:35.75万
成交额:275.40万
市值:4.60亿
市盈率:-2.52
高:7.81
开:7.43
低:7.38
收:7.35
数据加载中...
2024/06/03

重要事件披露

Form 8-K - Current report
2024/06/01

SEC问询函

Form CORRESP - Correspondence
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/24

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/16

重要事件披露

Form 8-K - Current report
2024/03/14

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/14

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities